Phase 2 study of weekly oxaliplatin and capecitabine in combination with preoperative radiotherapy in patients with MRI defined locally advanced rectal cancer.

Trial Profile

Phase 2 study of weekly oxaliplatin and capecitabine in combination with preoperative radiotherapy in patients with MRI defined locally advanced rectal cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Dec 2009

At a glance

  • Drugs Capecitabine; Oxaliplatin
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Acronyms CORE
  • Most Recent Events

    • 30 Oct 2005 Results presented at the 13th European Cancer Conference (ECCO) 2005.
    • 16 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top